Potocnik Uros, Ravnik-Glavac Metka, Glavac Damjan
Laboratory of Molecular Genetics, Institute of Pathology, Ljubljana, Slovenia.
Cell Mol Biol Lett. 2002;7(1):92-5.
The multidrug resistance 1 (MDRI) gene and transcription factor 4(TCF4) gene are suggested to be involved in the WNT signalling pathway, the most important pathway altered in colorectal cancer. Mutations in both genes have been identified and associated with colorectal tumors exhibiting high microsatellite instability (MSI-H). In this study, we report on the distribution of functional polymorphisms in the MDR] gene and somatic frameshift mutations in the TCF4 gene coding mononucleotide repetition in 62 MSI-H colorectal tumors. Somatic frameshift mutations in(of) the TCF4 gene were identified in 24/62 (39%) of the studied MSI-H tumors. The estimated allele frequencies of functional polymorphisms in(of) exon 21 (2677 G>T, Ala893Ser) and exon 26(3435 C>T, Ilel 142I1e) of the MDR] gene were 0.42 and 0.46 in the controls and 0.54 (p=0.035) and 0.60 (p=0.017) in the MSI-H tumors. However, the allele frequency of both functional MDR] polymorphisms did not significantly differ between MSI-H tumors with TCF4 mutations and those without. These results support the involvement of the MDRI gene in the tumorgenesis of MSI-H tumors and also suggest that functional polymorphisms in the MDRI gene and mutations in the TCF4 gene are likely to occur independently in MSI-H tumors.
多药耐药1(MDR1)基因和转录因子4(TCF4)基因被认为参与了WNT信号通路,这是在结直肠癌中改变的最重要通路。已在这两个基因中鉴定出突变,并与表现出高微卫星不稳定性(MSI-H)的结直肠肿瘤相关。在本研究中,我们报告了62例MSI-H结直肠肿瘤中MDR1基因功能多态性的分布以及TCF4基因编码单核苷酸重复序列中的体细胞移码突变。在24/62(39%)的研究的MSI-H肿瘤中鉴定出了TCF4基因的体细胞移码突变。MDR1基因外显子21(2677 G>T,Ala893Ser)和外显子26(3435 C>T,Ile1142Ile)功能多态性的估计等位基因频率在对照组中分别为0.42和0.46,在MSI-H肿瘤中分别为0.54(p=0.035)和0.60(p=0.017)。然而,在有TCF4突变的MSI-H肿瘤和无TCF4突变的MSI-H肿瘤之间,两种功能性MDR1多态性的等位基因频率没有显著差异。这些结果支持MDR1基因参与MSI-H肿瘤的肿瘤发生,也表明MDR1基因的功能多态性和TCF4基因的突变在MSI-H肿瘤中可能独立发生。